Infertility

The court made the decision yesterday, a year after a case was filed by a Katmandu-based women's rights group, Forum for Women, Law and Development.

Under the overturned law, men were able to file for divorce if they could prove through a doctor their wives were unable to conceive for 10 years.

The women's group argued men were also responsible for couple not being able to have children, which the law did not consider.

A study by the group in 2000 showed that the existing laws in Nepal had 118 provisions which discriminated against women and needed to be changed.

International Weather Bangalore Chennai Hyderabad Delhi Thiruvananthapuram Cities Bangalore Chennai Delhi Hyderabad Kolkata Mumbai Pondicherry Thiruvananthapuram Sections: Top Stories Business Line News Upda...

The company generates three-quarters of its sales from the multiple-sclerosis medicine Rebif, which was first sold in 1998, and fertility drug Gonal-f, the first biological copy of a follicle-stimulating hormone, that was approved for sale in 1995.

Rebif faces competition from new oral treatments as well as Elan Corp.'s Tysabri, which may return to the market in coming months.

First Signal The announcement ``is a first signal the company is not up for sale,'' Lombard Odier Darier Hentsch analyst Bob Pooler said in a note to investors.

``The company will become more aggressive in strengthening its product portfolio to reduce the dependency on flagship MS treatment Rebif.'' The drugmaker has been buying products to revive growth and move into new disease areas such as oncology and dermatology.

It acquired rights to Genentech Inc.

and Xoma Ltd.'s psoriasis therapy Raptiva outside the U.S.

and Asia and experimental cancer drugs from companies including Genmab A/S and Rigel Pharmaceuticals Inc.

Some of the drugs the company bought as well as those it developed weren't successful.

Serono dropped the development of psoriasis treatment onercept and melanoma drug Canvaxin in April 2005 and The company had to pay $725 million last year to settle...

But the major benefit of the interventional radiology procedure is there's less pain, one day out of work and less cost."White's study, released this week, shows enhancements to the non-surgical procedure which he describes as a major contribution to men's health.

Patients with pain while exercising can return to normal athletic activity, pain-free, within a few days of undergoing embolization, compared to 6 weeks with surgery.

The procedure also reverses testicular atrophy in adolescents and improves fertility rates in men.This is Carolyn Murphy.Suggested anchor close: To learn more about varicoeceles and men's health, visit www.SIRweb.org.AUDIO PROVIDED BY: Society of Interventional Radiology Source: Society of Interventional Radiology Email Story Set News Alert Print Story Finance Spotlight · Copyright © 2006 Yahoo!

Inc.

All rights reserved.

Privacy Policy - Terms of ServiceCopyright © 2006 PR Newswire.

All rights reserved.

Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire.

PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

...